Old College Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio


VerbaFlo lands a £5m seed round led by Pi Labs to power global real estate communications with conversational AI
VerbaFlo is a conversational AI platform for real estate owners and operators. It automates leasing, operations and resident engagement by managing property-related communications and workflows across multiple channels.


BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy
BIOCAPTIVA develops magnetic bead technology that prepares blood samples for liquid biopsy testing. Its platform captures cell-free DNA directly from whole blood to improve how samples are processed for cancer research and diagnostics.


Carbogenics secures £2.2m in funding led by Green Angel Ventures to tackle biomass waste with carbon removal tech
Carbogenics converts hard to recycle biomass waste into biocarbon products used in energy, water and industrial processes, aiming to remove carbon permanently while improving performance in sectors such as biogas and wastewater treatment.


Neuranics raises £6m seed led by Blackfinch Ventures to commercialise magnetic sensing for XR and wearables
Neuranics develops ultra-sensitive magnetic sensors that enable contactless monitoring of muscle and heart signals, supporting gesture recognition and biometric tracking in wearables and XR devices.


uFraction8 secures £3.4m in further funding post Foresight investment to advance biotech filtration technology
uFraction8 develops microfiltration technology for bioprocessing, enabling more efficient and scalable production of cells and biomass for food, feed and biopharma applications through lower-energy, continuous separation methods.


Concinnity Genetics raises £3m seed round led by Eos Advisory to establish RNA-based gene therapy control systems
Concinnity Genetics develops RNA based control systems that allow gene and cell therapies to be adjusted after dosing, improving safety and flexibility in advanced medical treatments.


Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology
Cytomos builds scalable cell analysis technology that measures intrinsic cellular properties in real time, helping biopharma companies accelerate drug discovery and manufacturing decisions.
More venture news
- 17 Apr 2026

UrFutureurfuture raises a £1.7m seed round led by River Capital to rebuild entry-level hiring
SeedHR - 13 Apr 2026

Round TreasuryRound announces its £4.5m seed round led by Alstin Capital to unify finance into one command system
SeedEnterprise - 7 Apr 2026

Trent AITrent AI launches from stealth with £10m seed round led by LocalGlobe and Cambridge Innovation Capital to provide layered security for AI agents
SeedCybersecurity